Difficulty: Medium
Average Score: 93%
Practice
Which of the following medications is a leukotriene receptor antagonist used in the treatment of asthma?
Correct answer
C
Rationale
The correct answer is C) Zafirlukast, a leukotriene receptor antagonist used in the treatment of asthma. Leukotrienes are inflammatory mediators that play a crucial role in asthma pathophysiology. By blocking leukotriene receptors, Zafirlukast helps reduce inflammation, bronchoconstriction, and mucus production in the airways, thus improving asthma symptoms and control.
A) Salbutamol is a short-acting beta-agonist that works by relaxing the muscles in the airways, providing quick relief of asthma symptoms, but it does not target leukotrienes.
B) Fluticasone is an inhaled corticosteroid that helps reduce airway inflammation in asthma by suppressing the immune response, but it does not act on leukotriene receptors.
D) Cromolyn is a mast cell stabilizer that prevents the release of inflammatory mediators, but it does not specifically target leukotriene receptors like Zafirlukast does.
Understanding the mechanisms of action of different asthma medications is crucial for nurses and healthcare professionals to make informed decisions in managing asthma effectively. Knowing which medications target specific pathways in asthma can help tailor treatment plans to individual patient needs, optimizing asthma control and improving patient outcomes.
A) Salbutamol is a short-acting beta-agonist that works by relaxing the muscles in the airways, providing quick relief of asthma symptoms, but it does not target leukotrienes.
B) Fluticasone is an inhaled corticosteroid that helps reduce airway inflammation in asthma by suppressing the immune response, but it does not act on leukotriene receptors.
D) Cromolyn is a mast cell stabilizer that prevents the release of inflammatory mediators, but it does not specifically target leukotriene receptors like Zafirlukast does.
Understanding the mechanisms of action of different asthma medications is crucial for nurses and healthcare professionals to make informed decisions in managing asthma effectively. Knowing which medications target specific pathways in asthma can help tailor treatment plans to individual patient needs, optimizing asthma control and improving patient outcomes.